Compositions and methods for immune cell modulation in adoptive immunotherapies
US-12036241-B2 · Jul 16, 2024 · US
Robbins David is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Robbins David |
| Total patents | 18 |
| First publication | Sep 27, 2016 |
| Latest publication | Jul 16, 2024 |
Publications ranked by popularity score, then publication date.
US-12036241-B2 · Jul 16, 2024 · US
US-2023182041-A1 · Jun 15, 2023 · US
US-2022118021-A1 · Apr 21, 2022 · US
US-2022054553-A1 · Feb 24, 2022 · US
US-11052118-B2 · Jul 6, 2021 · US
US-10980838-B2 · Apr 20, 2021 · US
US-2020179451-A1 · Jun 11, 2020 · US
US-2020172870-A1 · Jun 4, 2020 · US
US-10354994-B2 · Jul 16, 2019 · US
US-2019119635-A1 · Apr 25, 2019 · US
Latest publications not already listed above.
US-2019111085-A1 · Apr 18, 2019 · US
US-2019015454-A1 · Jan 17, 2019 · US
US-10172888-B2 · Jan 8, 2019 · US
US-10111907-B2 · Oct 30, 2018 · US
US-2018112180-A1 · Apr 26, 2018 · US
US-2017278840-A1 · Sep 28, 2017 · US
US-2017049820-A1 · Feb 23, 2017 · US
US-9452186-B2 · Sep 27, 2016 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Fate Therapeutics Inc | 15 |
| Juno Therapeutics Inc | 2 |
| Qorvo Us Inc | 2 |
| Medimmune Llc | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 13 |
| C12N2501/02 | 13 |
| A61P37/06 | 12 |
| C12N5/0647 | 12 |
| A61P29/00 | 12 |